401,985 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 401,985 shares of the company's stock, valued at approximately $4,358,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.30% of AdaptHealth at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in AHCO. Geode Capital Management LLC boosted its position in shares of AdaptHealth by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock valued at $23,499,000 after buying an additional 16,596 shares during the period. Wells Fargo & Company MN boosted its position in shares of AdaptHealth by 36.1% during the fourth quarter. Wells Fargo & Company MN now owns 54,546 shares of the company's stock valued at $519,000 after buying an additional 14,460 shares during the period. Bank of Montreal Can boosted its position in shares of AdaptHealth by 13.1% during the fourth quarter. Bank of Montreal Can now owns 28,558 shares of the company's stock valued at $272,000 after buying an additional 3,299 shares during the period. Invesco Ltd. boosted its position in shares of AdaptHealth by 12.2% during the fourth quarter. Invesco Ltd. now owns 1,433,172 shares of the company's stock valued at $13,644,000 after buying an additional 155,838 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in shares of AdaptHealth during the fourth quarter valued at approximately $197,000. 82.67% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on AHCO shares. Truist Financial lowered their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Royal Bank Of Canada lowered their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Finally, Wall Street Zen upgraded AdaptHealth from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Stock Down 0.1%

NASDAQ:AHCO traded down $0.01 during trading hours on Friday, reaching $9.48. The company's stock had a trading volume of 688,434 shares, compared to its average volume of 1,261,811. The company has a market capitalization of $1.28 billion, a P/E ratio of 17.56, a price-to-earnings-growth ratio of 1.06 and a beta of 1.58. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.70. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. The stock has a 50 day moving average price of $9.15 and a two-hundred day moving average price of $9.28.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.